Group 1: Project Updates - The Yancheng Lianhua project received government approval for trial production in March 2015 and is currently in normal production and sales, generating expected benefits [1] - Other projects are actively seeking approval, but the timeline for trial production permits is uncertain [1] Group 2: Safety and Environmental Concerns - The company emphasizes the importance of safety in the production of phosgene, a toxic gas, and has heightened safety awareness following the Tianjin hazardous chemical explosion [1][2] - The company is committed to strict adherence to environmental laws and regulations, implementing proactive measures to reduce pollution and enhance environmental protection as a core competitive advantage [2][3] Group 3: Management and Talent Acquisition - The addition of Mr. Andreas, with experience in multinational companies, is expected to enhance the company's management in areas such as R&D, quality control, and supply chain management [2] - The company plans to recruit more international talent to further its globalization efforts [2] Group 4: Business Performance and Outlook - The pharmaceutical and intermediate business, while currently small, has a stable profit model and sufficient product pipeline for future revenue [2] - The company expects a net profit growth of 10%-30% for the first nine months of 2015 compared to the same period last year [3] - Currency fluctuations, particularly the depreciation of the RMB, are anticipated to have a positive impact on the company's performance due to its primary business being export-oriented [2]

Group 1: Company Overview and Leadership - The new executive Andreas has joined the company to enhance its pharmaceutical and pharmaceutical intermediate business development [1][2] - The company has established strong partnerships with major international pharmaceutical companies, providing opportunities for growth [2][3] Group 2: Business Growth and Strategy - The company anticipates stable growth in its pesticide and pesticide intermediate business over the next 3 to 5 years [2][4] - The company is exploring mergers and acquisitions as part of its 2020 strategic plan, focusing on both pesticide and pharmaceutical sectors [2][3] Group 3: Service Offerings and Market Position - The company provides two types of services: customized product services and new service models, including R&D services [2][4] - The company positions itself as a leading CMO (Contract Manufacturing Organization) with a strong reputation in both domestic and international markets [4][5] Group 4: Market Dynamics and Challenges - The expiration of patents in the pharmaceutical industry is expected to have a significant price impact but limited quantity impact on the market [4][5] - The company is aware of the competitive landscape and aims to leverage its experience in pesticide production to enhance its pharmaceutical capabilities [4][5] Group 5: Environmental and Safety Investments - The company invested over 100 million in environmental protection in 2014, emphasizing the importance of sustainable development [5]

联化科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------|-----------------------------------------------------|--------|--------|-------|--------|---------------------|---------------------------|---------------|----------|--------|--------| | 证券代码： \n投资者关系活动类别 | 002250 \n□特定对象调研 | | | | | □分析师会议 | 证券简称：联化科技 编号： | | 20151028 | | | | | □媒体采访 □业绩说明会 | | | | | | | | | | | | | □新闻发布会 □路演活动 | | | | | | | | | | | | | □现场参观 √其他（投资者交流会--公司事业部发 ...

联化科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | |-----------------------|----------------------------------------------------------------------------------------------------------------|-------|-------|-------|-------------------------------------------------------------| | 证券代码： 002250 | 证券简称：联化科技 | | | | 编号：20141112 | | 投资者关系活动类别 | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | | | | □新闻发布会 □路演活动 | | | | | | | □现场参观 □其他（投资者接待日活动） | | | | | | 参与单位名称及人员 | 兴业全球基金 陈锦泉 朱 璘 | | | | | | 姓名 | 华安基金 曾 ...

联化科技股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | --- | |--------------------|----------------------------------------------|-------------------------------|-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|------------------| | 证券代码： 002250 | | 证券简称：联化科技 | | 编号：20150428 | | | 投资者关系活动类别 | | | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | | | | □新闻发布会 □路演活动 | | | | | | | | □现场 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150528 | --- | --- | --- | --- | |-------------------------|--------------------------------------|-------------|----------------------------------------------------------------| | | | | | | 投资者关系活动类别 | √特定对象调研 | □分析师会议 | | | | □媒体采访 □业绩说明会 | | | | | □新闻发布会 □路演活动 | | | | | | | □现场参观 □其他（投资者接待日活动） | | 参与单位名称及人员 姓名 | 首域投资(香港)有限公司 柯雷 陈希骅 | | | | 时间 | 2015 年 05 月 28 日 | | | | 地点 黄岩 | | | | | 上市公司接待人员姓 名 | 高级副总裁/董秘/财务总监 | | 陈飞彪 证券事务代表 任安立 | | 投资者关系活动主要 | 1. | | 公司的 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150313 | --- | --- | --- | --- | --- | --- | |-------------------------|------------------------------------|----------------|--------|------------------------------------------|-----------------------------------------------------------------------------------------------------------| | | | | | | | | 投资者关系活动类别 | | | | √特定对象调研 □分析师会议 | | | | | | | □媒体采访 □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | | | | | | | □现场参观 □其他（投资者接待日活动） | | | 参与单位名称及人员 姓名 | 国泰投信 江宏儒、蔡佩芬 | | | ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20150619 | --- | --- | --- | --- | --- | |-----------------------------|-------------------------------------------------------------------------------|-------------|---------------------|--------------------------------------------------------------| | | | | | | | 投资者关系活动类别 | √特定对象调研 | □分析师会议 | | | | | □媒体采访 □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 □其他（投资者接待日活动） | | | | | 参与单位名称及人员 姓名 | 平安证券 郭哲 北京睿谷投资 | | | 叶侃 | | 时间 | 2015 年 06 月 19 日 | | | | | 地点 黄岩 ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20160812 | --- | --- | --- | --- | --- | |--------------------|---------------------------------------|------------------------------|---------------------|----------------------------------------------------------------| | | | | | | | 投资者关系活动类别 | □特定对象调研 □媒体采访 □业绩说明会 | □分析师会议 | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 √其他（投资者接待日活动） | | | | | 参与单位名称及人员 | 详见附件清单 | | | | | 姓名 | | | | | | 时间 | 2016 年 08 月 12 日 | | | | | 地点 黄岩 | | | | | | 上市公司接待人员姓 | 董事长/总裁 王萍 | 董事/ | ...

联化科技股份有限公司投资者关系活动记录表 证券代码：002250 证券简称：联化科技 编号：20160519 | --- | --- | --- | --- | --- | |----------------------------------------------------|---------------------------------------------|--------------|-----------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------| | 投资者关系活动类别 \n \n参与单位名称及人员 姓名 | √特定对象调研 \n南方基金 杜冬松 周 方正证券 | \n 郭艳红 | □分析师会议 \ ...